As a Barclays analyst put it, it’s been a “slow-moving car crash”. Early supply shortages pushed patients to competitors, ...

CNBC's Karen Gilchrist discusses Wegovy-maker Novo Nordisk's efforts to regain U.S. market share amid increased competition ...

Denmark’s status as one of the few countries in Europe with an expanding economy rests in part on the success of its ...

The pharmaceutical giant cut its guidance and said U.S. sales of Ozempic grew more slowly.

In short, Guinness sales are soaring. In fact, Wetherspoons cited the Irish stout as a “standout performer” allowing the pub ...

Novo Nordisk's CFO Karsten Munk Knudsen says the drugmaker is already meeting some of the demands set out by Donald Trump in ...

Some of the most recognizable brand names that could be impacted by new tariffs include Ozempic and Wegovy, two injectable drugs that have grown popular in recent years for their abilities to ...

You’ll pay more for a German car or Swiss cheese, but the EU enjoys zero tariffs on American goods. That’s a bad deal. | ...

Danish pharmaceutical giant Novo Nordisk posted a sharp rise in second-quarter net profit Wednesday, but rising competition ...

A 3D scan of the USS Albacore’s propeller at Albacore Park sparks new STEM outreach efforts and highlights advances in marine ...

For outsourcing and manufacturing professionals, 2024 may be remembered as the year capacity and partnerships took center ...

COPENHAGEN (Reuters) -Novo Nordisk expects continued competition from copycat versions of its blockbuster Wegovy obesity drug ...